The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

David J. Moliterno; Khaled M. Ziada

doi:10.1016/j.jacc.2007.10.025

The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

David J. Moliterno
, Khaled M. Ziada

Producción científica: Editorial

8 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	536-537
Número de páginas	2
Publicación	Journal of the American College of Cardiology
Volumen	51
N.º	5
DOI	https://doi.org/10.1016/j.jacc.2007.10.025
Estado	Published - feb 5 2008

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1016/j.jacc.2007.10.025

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.'. En conjunto forman una huella única.

Citar esto

Moliterno, D. J., & Ziada, K. M. (2008). The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology, 51(5), 536-537. https://doi.org/10.1016/j.jacc.2007.10.025

Moliterno, David J. ; Ziada, Khaled M. / The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. En: Journal of the American College of Cardiology. 2008 ; Vol. 51, N.º 5. pp. 536-537.

@article{64daab6d126c45a68d14658da3e9f2ab,

title = "The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.",

author = "Moliterno, \{David J.\} and Ziada, \{Khaled M.\}",

year = "2008",

month = feb,

day = "5",

doi = "10.1016/j.jacc.2007.10.025",

language = "English",

volume = "51",

pages = "536--537",

number = "5",

}

Moliterno, DJ & Ziada, KM 2008, 'The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.', Journal of the American College of Cardiology, vol. 51, n.º 5, pp. 536-537. https://doi.org/10.1016/j.jacc.2007.10.025

The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. / Moliterno, David J.; Ziada, Khaled M.
En: Journal of the American College of Cardiology, Vol. 51, N.º 5, 05.02.2008, p. 536-537.

Producción científica: Editorial

TY - JOUR

T1 - The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

AU - Moliterno, David J.

AU - Ziada, Khaled M.

PY - 2008/2/5

Y1 - 2008/2/5

UR - https://www.scopus.com/pages/publications/38349121568

UR - https://www.scopus.com/pages/publications/38349121568#tab=citedBy

U2 - 10.1016/j.jacc.2007.10.025

DO - 10.1016/j.jacc.2007.10.025

M3 - Editorial

C2 - 18237681

AN - SCOPUS:38349121568

SN - 0735-1097

VL - 51

SP - 536

EP - 537

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 5

ER -

Moliterno DJ, Ziada KM. The Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors for Primary Angioplasty. More Options to Choose and More Time to Decide^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2008 feb 5;51(5):536-537. doi: 10.1016/j.jacc.2007.10.025